Stephen J Wood (S J Wood, Stephen Wood)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Cardiac Resynchronization Therapy

Systematic Review

Intensive Care Unit

Hepatitis B Virus

Top Venues

Journal of diabetes

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

Diabetic medicine : a journal of the British Diabetic Association

This page only lists publications with an associated author ORCID identifier.

Publications

Kate E D Ziser, Adam C Livori MClinPharm, Jedidiah I Morton, Adaire E Prosser, Jenni S Ilomaki, Stephen J Wood
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review. British journal of clinical pharmacology 90 (7) (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
George S Q Tan, Jedidiah I Morton, Stephen J Wood, Jonathan Edward Shaw, Dianna J Magliano, Jenni S Ilomaki
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors. Clinical pharmacology and therapeutics (2024)
Kate E D Ziser, Adam C Livori MClinPharm, Jedidiah I Morton, Adaire E Prosser, Jenni S Ilomaki, Stephen J Wood
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review. British journal of clinical pharmacology 90 (7) (2024)
Kate E D Ziser, Adam C Livori MClinPharm, Jedidiah I Morton, Adaire E Prosser, Jenni S Ilomaki, Stephen J Wood
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review. British journal of clinical pharmacology (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
George S Q Tan, Jedidiah I Morton, Stephen J Wood, Jonathan Edward Shaw, Dianna J Magliano, Jenni S Ilomaki
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors. Clinical pharmacology and therapeutics 115 (6) (2024)
George S Q Tan, Jedidiah I Morton, Stephen J Wood, Jonathan Edward Shaw, Dianna J Magliano, Jenni S Ilomaki
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors. Clinical pharmacology and therapeutics 115 (6) (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
Stephen J Wood, D J Magliano, J S Bell, J E Shaw, C S Keen, J Ilomäki
Pharmacological treatment initiation for type 2 diabetes in Australia: are the guidelines being followed? Diabetic medicine : a journal of the British Diabetic Association 37 (8) (2019)